NHS Midlands & East Framework for Denosumab 60mg PFS
Details
- Buyer
- NHS England
- Value
- £600,000
- Topic
- Pharmaceutical products
- Published
- 18 September 2026
- Submission
- 13 October 2026
- Source
- uk:find_a_tender
Tender description
Project title: NHS Midlands & East Framework for Denosumab 60mg PFS Offer reference number: CM/TNS/26/5768 Period of framework: 01 January 2027 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 16 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Timeline
- Completed: Tender published18 September 2026Current notice
- Completed: Submission date13 October 2026
About the buyer
NHS England is a public sector buyer in the United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
11 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 490£235.8m
- 427£6.2bn
- 396£107.7m
- 385£648.7m
- 312£1.2bn
- 311£24.2bn
- 281£1.6bn
- 250£3.0bn
- 151£113.9m
- 147£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.